Literature DB >> 11177699

Kidney disease in patients with chronic hepatitis C.

M Philipneri1, B Bastani.   

Abstract

There is an increasing recognition of the association between chronic hepatitis C virus infection and glomerular diseases. Renal complications may be the presenting manifestation of hepatitis C virus infection. Patients may present with signs and symptoms of cryoglobulinemic systemic vasculitis, proteinuria, microscopic hematuria, acute renal failure, or nephrotic syndrome. The pathogenesis of hepatitis C virus associated with renal disease remains incompletely understood; however, deposition of circulating immune complexes in the subendothelial space and mesangium in the glomeruli seems to play a major role. The most common renal pathology associated with hepatitis C virus infection is type I membranoproliferative glomerulonephritis with or without cryoglobulinemia. In patents who do not have significant renal impairment, combination therapy with interferon alfa (IFN-alpha) and ribavirin seems to be the treatment of choice, although the experience with this combination is quite limited in patients with renal involvement. A prolonged course of high-dose IFN-alpha has been most commonly used for these patients with significant success, but relapse of hepatitis C viremia and renal disease after discontinuation of therapy have frequently occurred.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11177699     DOI: 10.1007/s11894-001-0045-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  29 in total

1.  Hepatitis-C-virus-associated cryoglobulinaemic membranoproliferative glomerulonephritis in patients infected by HIV.

Authors:  E Morales; R Alegre; J C Herrero; J M Morales; T Ortuño; M Praga
Journal:  Nephrol Dial Transplant       Date:  1997-09       Impact factor: 5.992

2.  Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis.

Authors:  D Sansonno; L Gesualdo; C Manno; F P Schena; F Dammacco
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

3.  Membranoproliferative glomerulonephritis and hepatitis C infection.

Authors:  J R Harlé; P Disdier; B Dussol; G Bolla; P Casanova; P J Weiller
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

4.  High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis?

Authors:  A Fornasieri; S Armelloni; P Bernasconi; M Li; C P de Septis; R A Sinico; G D'Amico
Journal:  Am J Kidney Dis       Date:  1996-04       Impact factor: 8.860

5.  Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.

Authors:  R Misiani; P Bellavita; D Fenili; O Vicari; D Marchesi; P L Sironi; P Zilio; A Vernocchi; M Massazza; G Vendramin
Journal:  N Engl J Med       Date:  1994-03-17       Impact factor: 91.245

6.  Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.

Authors:  T Poynard; V Leroy; M Cohard; T Thevenot; P Mathurin; P Opolon; J P Zarski
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

7.  Diffuse proliferative glomerulonephritis with hepatitis C virus-like particles in paramesangial dense deposits in a patient with chronic hepatitis C virus hepatitis.

Authors:  S Horikoshi; T Okada; I Shirato; S Inokuchi; H Ohmuro; Y Tomino; H Koide
Journal:  Nephron       Date:  1993       Impact factor: 2.847

8.  Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan.

Authors:  H Yamabe; R J Johnson; D R Gretch; K Fukushi; H Osawa; M Miyata; H Inuma; T Sasaki; M Kaizuka; N Tamura
Journal:  J Am Soc Nephrol       Date:  1995-08       Impact factor: 10.121

9.  Membranous glomerulonephritis in association with hepatitis C virus infection.

Authors:  R Davda; J Peterson; R Weiner; B Croker; J Y Lau
Journal:  Am J Kidney Dis       Date:  1993-09       Impact factor: 8.860

10.  Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy.

Authors:  R J Johnson; D R Gretch; W G Couser; C E Alpers; J Wilson; M Chung; J Hart; R Willson
Journal:  Kidney Int       Date:  1994-12       Impact factor: 10.612

View more
  5 in total

1.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Infection       Date:  2018-09-25       Impact factor: 3.553

2.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  J Nephrol       Date:  2018-09-25       Impact factor: 3.902

3.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Intern Emerg Med       Date:  2018-09-25       Impact factor: 3.397

Review 4.  Hepatitis C virus associated glomerulopathies.

Authors:  Abdullah Ozkok; Alaattin Yildiz
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 5.  Infection and glomerulonephritis.

Authors:  Saraladevi Naicker; June Fabian; Sagren Naidoo; Shoyab Wadee; Graham Paget; Stewart Goetsch
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.